Slap restricts oncogenic Src-family kinase signaling to maintain colonic epithelial homeostasis
Year: 2026
Type: article
Abstract: ABSTRACT Src-family kinases (SFKs) regulate proliferation in colonic epithelial cells (CECs), but the mechanisms that restrain their activity remain poorly defined. We identify Src-like adaptor protein (SLAP), a negative regulator of receptor tyrosine kinase signaling, as a key suppressor of SFK activity in the colon. Constitutive and inducible epithelial-specific Slap deletion using a villin-CreERT2 model increases CEC proliferation and accelerates tumorigenesis in the azoxymethane/dextran sodium sulfate (AOM/DSS) model. Slap deficiency also enhances SFK-dependent expansion of normal and tumor-derived colonic organoids. Mechanistically, we identify the receptor tyrosine kinase EPHB2 as a critical upstream activator of SFKs and a direct target of SLAP-mediated regulation. Loss of Slap increased EphB2 protein abundance and tyrosine phosphorylation and enhanced its association with active SRC. Pharmacological inhibition of EPHB2 suppressed SRC activation and reversed the hyperproliferative phenotype induced by Slap deficiency. Together, these findings uncover a non-genetic mechanism driving SFK activation during colonic transformation and establish SLAP as a tumor suppressor that constrains oncogenic EPHB2–SFK signaling in the colonic epithelium.
Source: eLife
Institutions: Centre National de la Recherche Scientifique, Université de Montpellier, Centre de Recherche en Biologie cellulaire de Montpellier, Institut Pasteur, Université Paris Cité, Department of Genomes & Genetics, Inserm, Institut de Génomique Fonctionnelle, Institut de Génétique Moléculaire de Montpellier, Institut de Recherche en Cancérologie de Montpellier
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $2,500
Funders: Biogen, Agence Nationale de la Recherche, Institut National de la Santé et de la Recherche Médicale, Fondation pour la Recherche Médicale, Ligue Contre le Cancer, Centre National de la Recherche Scientifique, Institut National Du Cancer, Université de Montpellier, Direction Générale de l’offre de Soins, Région Occitanie Pyrénées-Méditerranée, European Regional Development Fund
OpenAlex ID: W7118177244
